ETFs positioned on Bio-Techne Corporation

Name Weight AuM 1st Jan change Investor Rating
2.93% 1 M€ 0.00% -
2.50% 0 M€ -1.80% -
2.15% 0 M€ -.--%
1.25% 0 M€ 0.00% -
1.13% 0 M€ 0.00% -
0.74% 0 M€ -.--% -
0.54% 30 M€ -1.44% -
0.36% 0 M€ +11.32%
0.35% 3 M€ -.--%
0.17% 0 M€ -.--% -
0.16% 128 M€ -0.42%
0.12% 0 M€ -72.95% -
0.12% 12 M€ +0.22%
0.12% 0 M€ +12.96% -
0.12% 0 M€ +12.98% -
0.08% 0 M€ +17.41%
0.06% 0 M€ -.--% -
0.06% 0 M€ +14.69% -
0.06% 0 M€ +15.64% -
0.06% 0 M€ +14.54% -
0.06% 0 M€ -.--%
0.05% 0 M€ +11.40% -
0.05% 10 M€ -1.24% -
0.05% 693 M€ -0.21%
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.4%). Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).
Employees
3,100
More about the company
Trading Rating
Investor Rating
ESG MSCI
A
surperformance-ratings-light-chart BIO-TECHNE-CORPORATIONMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
74.73USD
Average target price
85.26USD
Spread / Average Target
+14.09%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. TECH Stock
  4. ETFs Bio-Techne Corporation